Abstract

4028 Background: From 2009-2012, 1020 pts were enrolled in two phase III, randomized, double-blind studies of RAM in metastatic gastroesophageal junction and gastric adenocarcinoma following progre...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Real-world outcomes of second-line ramucirumab plus paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma: A nationwide retrospective study in Korea (KCSG-ST19-16).
Dae Young Zang ... Young Ju Suh
Journal of Clinical Oncology | VOL. 39
Dae Young Zang, et. al.Dae Young Zang ... Young Ju Suh
20 May 2021
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer.
...
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | VOL. 22
, et. al. ...
07 Aug 2018
P-352 Docetaxel, oxaliplatin, and 5-fluorouracil in metastatic gastric/gastroesophageal junction adenocarcinoma: A single-center experience
H Engin ... G Çevik
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 31
H Engin, et. al.H Engin ... G Çevik
01 Jul 2020
Efficacy and safety of first-line systemic chemotherapy with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil regimens in locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma: A prospective phase II study from South India.
T Chaudhuri ... L Dasappa
Indian Journal of Cancer | VOL. 54
T Chaudhuri, et. al.T Chaudhuri ... L Dasappa
01 Jan 2017
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
It Mattered Later: A Patient-Turned-Doctor's Perspective on Fertility Loss.
Margaret Cupit-Link
Journal of Clinical Oncology | VOL. -
Margaret Cupit-LinkMargaret Cupit-Link
23 Jul 2024
At the Crossroads of Local and Systemic Treatment of Operable Non-Small Cell Lung Cancer.
Rafal Dziadziuszko ... Witold Rzyman
Journal of Clinical Oncology | VOL. -
Rafal Dziadziuszko, et. al.Rafal Dziadziuszko ... Witold Rzyman
23 Jul 2024
Management of Stage III Non-Small Cell Lung Cancer: ASCO Rapid Recommendation Update.
Megan E Daly ...
Journal of Clinical Oncology | VOL. -
Megan E Daly, et. al.Megan E Daly ...
23 Jul 2024
Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease.
Connor Lynch ... Ralph R Weichselbaum
Journal of Clinical Oncology | VOL. -
Connor Lynch, et. al.Connor Lynch ... Ralph R Weichselbaum
22 Jul 2024
View more papers